![Ruby Casareno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ruby Casareno hat die Position des Vice President-Technical Operations bei Allakos, Inc. inne. Dr. Casareno erhielt einen Bachelor-Abschluss von der University of the Philippines und einen Doktortitel von der Ohio State University.
| Unternehmen | Position | Ende |
|---|---|---|
| ALLAKOS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2022 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Philippines
 University of the Philippines Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
 Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
